Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

ACC/AHA Hypertension Guideline Update: Recommendations for Managing Blood Pressure

Wang and colleagues analyzed data from nearly 105,000 patients to create and test a device that can predict the efficacy of various drug combinations for hypertension.

Antihypertensive Drug Efficacy Calculator Developed from 484 Clinical Trials With Nelson Wang, MD, PhD

An audio recap of the top 5 stories in healthcare news from the week of 08/31-9/5.

HCPLive 5 Stories in Under 5: Week of 08/31

The death rate from high blood pressure-related kidney disease increased by 48% from 1999-2023, with notable disparities by race, ethnicity, sex, and region.

Hypertensive Kidney Disease Death Rate Up 48% in Past 25 Years

Patel addresses the updated AHA/ACC hypertension guidelines, explaining important features and highlighting the potential of newer therapies.

Updating the Hypertension Treatment Landscape With Manesh Patel, MD

Bhalla breaks down the newer treatments included in the recently updated AHA/ACC hypertension management guidelines.

Leveraging New Therapies and Guidelines in Hypertension, With Vivek Bhalla, MD

A recap  8 clinical trials in cardiovascular care to know from the European Society of Cardiology Congress 2025.

ESC Congress 2025 Recap: 8 Trials to Know

Alnylam Pharmaceuticals debuts phase 2 KARDIA-3 data at ESC 2025 and advances zilebesiran into a phase 3 outcomes trial.

Zilebesiran, RNAi for Hypertension, Heads to Phase 3 Cardiovascular Outcomes Trial

Baxdrostat Proves Role of Aldosterone Inhibition in Hypertension, With Jenifer Brown, MD

The investigative aldosterone synthase inhibitor reduced seated systolic blood pressure in patients with uncontrolled or resistant hypertension compared to placebo.

BaxHTN: Baxdrostat Achieves Primary Endpoint in Treating Hypertension

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.